SK Biopharm Signs Contract to Supply Epilepsy Drug ‘Cenobamate’ to the US
(Health Korea News / Lee Chang-yong) SK Biopharmaceuticals announced through a public disclosure on the 18th that it has signed a contract to sell and supply its new epilepsy treatment drug ‘Cenobamate (US product name XCOPRI®)’ to its US subsidiary, … Read more